Saturday 5 September 2015
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Certification of Quality Management System for Medical Laboratories Complying with Medical Laboratory Standard, Ministry of Public Health
Department of Medical Sciences F0715102 Ministry of Public Health Certification of quality management system for medical laboratories complying with Medical Laboratory Standard, Ministry of Public Health Information date on 1 March 2019 new = initial accreditation, r1 = reassessment 1 , TS = Temporary Suspension, P = Process No. HCode Health RMSc Status Medical Laboratory Province Registration Accredited Expiration Region No. Date Date 1 10673 2 2 r1 Uttaradit Hospital Uttaradit 0001/2557 07/08/2017 06/08/2020 2 11159 2 2 r1 Tha Pla Hospital Uttaradit 0002/2557 07/08/2017 06/08/2020 3 11160 2 2 r1 Nam Pat Hospital Uttaradit 0003/2557 07/08/2017 06/08/2020 4 11161 2 2 r1 Fak Tha Hospital Uttaradit 0004/2557 07/08/2017 06/08/2020 5 11162 2 2 r1 Ban Khok Hospital Uttaradit 0005/2557 07/08/2017 06/08/2020 6 11163 2 2 r1 Phichai Hospital Uttaradit 0006/2557 07/08/2017 06/08/2020 7 11164 2 2 r1 Laplae Hospital Uttaradit 0007/2557 07/08/2017 06/08/2020 8 11165 2 2 r1 ThongSaenKhan Hospital Uttaradit 0008/2557 07/08/2017 06/08/2020 9 11158 2 2 r1 Tron Hospital Uttaradit 0009/2557 07/08/2017 06/08/2020 10 10863 4 4 r1 Pak Phli Hospital Nakhonnayok 0010/2557 07/08/2017 06/08/2020 11 10762 4 4 r1 Thanyaburi Hospital Pathum Thani 0011/2557 07/08/2017 06/08/2020 12 10761 4 4 r1 Klong Luang Hospital Pathum Thani 0012/2557 07/08/2017 06/08/2020 13 11141 1 1 P Ban Hong Hospital LamPhun 0014/2557 07/08/2014 06/08/2017 14 11142 1 1 P Li Hospital LamPhun 0015/2557 07/08/2014 06/08/2017 15 11144 1 1 P Pa Sang Hospital LamPhun 0016/2557 07/08/2014 06/08/2017 -
Estimating the Burden of Α-Thalassaemia in Thailand Using A
bioRxiv preprint doi: https://doi.org/10.1101/412718; this version posted September 12, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 Estimating the burden of α-thalassaemia in Thailand using a 2 comprehensive prevalence database for Southeast Asia 3 Carinna Hockham1,2*, Supachai Ekwattanakit3, Samir Bhatt4, Bridget S Penman5, 4 Sunetra Gupta2, Vip Viprakasit3,6 & Frédéric B Piel7 5 6 1The George Institute for Global Health, Sydney, Australia; 2 Evolutionary Ecology of 7 Infectious Disease Group, Department of Zoology, University of Oxford, Oxford, UK, 8 3Thalassaemia Centre, Faculty of Medicine, Siriraj Hospital, Mahidol University, 9 Bangkok, Thailand; 4Department of Infectious Disease Epidemiology, School of Public 10 Health, Imperial College, London, UK; 5Warwick Infectious Disease Epidemiology 11 Research, School of Life Sciences, Warwick University, Coventry, UK; 6Department of 12 Paediatrics, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, 13 Thailand; 7MRC-PHE Centre for Environment & Health, Department of Epidemiology 14 & Biostatistics, School of Public Health, Imperial College London, London, UK 15 16 *For correspondence: [email protected] 17 18 bioRxiv preprint doi: https://doi.org/10.1101/412718; this version posted September 12, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 19 Abstract 20 Severe forms of α-thalassaemia, haemoglobin H disease and haemoglobin Bart’s hydrops 21 fetalis, are an important public health concern in Southeast Asia. -
A Randomized Controlled Trial Comparing Concurrent
J Gynecol Oncol. 2019 Jul;30(4):e82 https://doi.org/10.3802/jgo.2019.30.e82 pISSN 2005-0380·eISSN 2005-0399 Original Article A randomized controlled trial comparing concurrent chemoradiation versus concurrent chemoradiation followed by adjuvant chemotherapy in locally advanced cervical cancer patients: ACTLACC trial Siriwan Tangjitgamol ,1 Ekkasit Tharavichitkul ,2 Chokaew Tovanabutra ,3 Kanisa Rongsriyam ,4 Tussawan Asakij ,5 Kannika Paengchit ,6 Jirasak Sukhaboon ,7 Somkit Penpattanagul ,8 Apiradee Kridakara ,9 Received: Oct 28, 2018 Jitti Hanprasertpong ,10 Kittisak Chomprasert ,3 Sirentra Wanglikitkoon ,8 Revised: Mar 18, 2019 10 11 4 Accepted: Mar 18, 2019 Thiti Atjimakul , Piyawan Pariyawateekul , Kanyarat Katanyoo , Prapai Tanprasert ,12 Wanwipa Janweerachai,13 Duangjai Sangthawan ,14 Correspondence to Jakkapan Khunnarong ,1 Taywin Chottetanaprasith ,15 Siriwan Tangjitgamol Busaba Supawattanabodee ,16 Prasert Lertsanguansinchai ,17 Department of Obstetrics and Gynecology, Jatupol Srisomboon ,18 Wanrudee Isaranuwatchai ,19,20 Vichan Lorvidhaya 3 Faculty of Medicine Vajira Hospital, Navamindradhiraj University, 681 Samsen 1Department of Obstetrics and Gynecology, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Road, Khet Dusit, Bangkok 10300, Thailand. Bangkok, Thailand E-mail: [email protected] 2Department of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand [email protected] 3Radiation Oncology Section, Chonburi Cancer Hospital, Chonburi, Thailand 4Department of Radiology, Faculty -
Clinical Epidemiology of 7126 Melioidosis Patients in Thailand and the Implications for a National Notifiable Diseases Surveilla
applyparastyle “fig//caption/p[1]” parastyle “FigCapt” View metadata, citation and similar papers at core.ac.uk brought to you by CORE Open Forum Infectious Diseases provided by Apollo MAJOR ARTICLE Clinical Epidemiology of 7126 Melioidosis Patients in Thailand and the Implications for a National Notifiable Diseases Surveillance System Viriya Hantrakun,1, Somkid Kongyu,2 Preeyarach Klaytong,1 Sittikorn Rongsumlee,1 Nicholas P. J. Day,1,3 Sharon J. Peacock,4 Soawapak Hinjoy,2,5 and Direk Limmathurotsakul1,3,6, 1Mahidol-Oxford Tropical Medicine Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand, 2 Epidemiology Division, Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand, 3 Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, Old Road Campus, University of Oxford, Oxford, United Kingdom, 4 Department of Medicine, University of Cambridge, Cambridge, United Kingdom, 5 Office of International Cooperation, Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand, and 6 Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand Background. National notifiable diseases surveillance system (NNDSS) data in developing countries are usually incomplete, yet the total number of fatal cases reported is commonly used in national priority-setting. Melioidosis, an infectious disease caused by Burkholderia pseudomallei, is largely underrecognized by policy-makers due to the underreporting of fatal cases via the NNDSS. Methods. Collaborating with the Epidemiology Division (ED), Ministry of Public Health (MoPH), we conducted a retrospec- tive study to determine the incidence and mortality of melioidosis cases already identified by clinical microbiology laboratories nationwide. A case of melioidosis was defined as a patient with any clinical specimen culture positive for B. -
Mortality Risk and Temporal Patterns of Atrial Fibrillation in the Nationwide
medRxiv preprint doi: https://doi.org/10.1101/2021.01.30.21250715; this version posted June 17, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Mortality Risk and Temporal Patterns of Atrial Fibrillation in the Nationwide Registry Apiyasawat Short Title: Mortality Risk in Non-paroxysmal AF Sirin Apiyasawat, MD1; Sakaorat Kornbongkotmas, MD2; Ply Chichareon, MD3; Rungroj Krittayaphong, MD4; for the COOL-AF Investigators Links to Affiliations: 1 Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand 2 Queen Savang Vadhana Memorial Hospital, Chonburi, Thailand 3 Faculty of Medicine, Prince of Songkla University, Songkla, Thailand 4 Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand Address for correspondence: Rungroj Krittayaphong, MD Division of Cardiology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand Phone: (66) 2-419-6104; Fax: (66) 2-412-7412, E-mail: [email protected] Word Count: 2299 NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2021.01.30.21250715; this version posted June 17, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . -
Course Description of Bachelor of Science in Paramedicine 1. General Education 1.1 Social Sciences and Humanities MUGE 101 Gener
Course Description of Bachelor of Science in Paramedicine 1. General Education 1.1 Social Sciences and Humanities MUGE 101 General Education for Human Development Pre-requisite - Well-rounded graduates, key issues affecting society and the environment with respect to one’ particular context; holistically integrated knowledge to identify the key factors; speaking and writing to target audiences with respect to objectives; being accountable, respecting different opinions, a leader or a member of a team and work as a team to come up with a systematic basic research-based solution or guidelines to manage the key issues; mindful and intellectual assessment of both positive and negative impacts of the key issues in order to happily live with society and nature SHHU 125 Professional Code of Ethics Pre-requisite - Concepts and ethical principles of people in various professions, journalists, politicians, businessmen, doctors, government officials, policemen, soldiers; ethical problems in the professions and the ways to resolve them SHSS 144 Principles of Communication Pre-requisite - The importance of communication; information transferring, understanding, language usage, behavior of sender and receiver personality and communication; effective communication problems in communication SHSS 250 Public Health Laws and Regulations Pre-requisite - Introduction to law justice procedure; law and regulation for doctor and public health practitioners, medical treatment act, practice of the art of healing act, medical service act, food act, drug act, criminal -
SET and SET Foundation Donate THB 5.8 Million to Help COVID-19-Ravaged People
SET News 29/2021 May 5, 2021 SET and SET Foundation donate THB 5.8 million to help COVID-19-ravaged people BANGKOK, May 5, 2021 - The Stock Exchange of Thailand (SET) and the SET Foundation have stepped up effort to those affected by the COVID-19 pandemic by donating THB 5.8 million (approx. USD 184,895) to 10 hospitals and public health organizations to purchase medical equipment and supplies. SET President and SET Foundation’s Member of the Board of Directors and Secretary, Pakorn Peetathawatchai, said that the new wave of COVID-19 has rapidly caused more new confirmed cases. According to the report by the Department of Disease Control as of April 30, 2021, April recorded 36,290 new cases or more than a half of the country’s cumulated cases at 65,153 patients. The central and the northern regions logged the highest and the second highest cases resulting in an urgent need of medical equipment and apparatus among hospitals and public health organizations to accommodate the increasing number of patients in time. “SET, together with the SET Foundation, has donated THB 5.8 million to certain hospitals and healthcare units directly involved with the patients’ treatment and care to acquire medical supplies to save lives of the patients in the affected communities. We consider this as a critical situation and sincerely care for people, reflecting SET’s vision ‘To Make the Capital Market Work for Everyone’. We are determined to develop the capital market to benefit all sectors and ready to take part in relieving the burden in times of trouble. -
Age-Related Clinical Outcomes of Patients with Non-Valvular Atrial Fibrillation: Insights from the COOL-AF Registry
Clinical Interventions in Aging Dovepress open access to scientific and medical research Open Access Full Text Article ORIGINAL RESEARCH Age-Related Clinical Outcomes of Patients with Non-Valvular Atrial Fibrillation: Insights from the COOL-AF Registry Rungroj Krittayaphong1 Purpose: We aimed to compare the rate of clinical outcomes among three age groups (<65, Thanita Boonyapiphat2 65–74, and ≥75 years) of adult patients with non-valvular atrial fibrillation (NVAF). Chaiyasith Wongvipaporn3 Patients and Methods: We prospectively enrolled NVAF patients from 27 Thailand Poom Sairat1 medical centers. The following were collected at baseline: demographic data, risk factors, comorbid conditions, laboratory data, and medications. The clinical outcomes were ischemic On behalf of the COOL-AF stroke (IS) or transient ischemic attack (TIA), major bleeding (MB), intracerebral hemor Investigators rhage (ICH), heart failure (HF), and death. All events were adjudicated. Patients were categorized according to age group into three groups; age <65, 65–74, and ≥75 years. 1Division of Cardiology, Department of Results: Among the 3402 patients that were enrolled during 2014–2017, the mean age was 67.4 Medicine, Faculty of Medicine Siriraj ±11.3 years, and 2073 (60.9%) were older. The average follow-up was 25.7±10.6 months. Oral Hospital, Mahidol University, Bangkok, Thailand; 2Division of Cardiology, anticoagulants were given in 75.4% of patients (91.1% of OAC was warfarin). The incidence rate Department of Medicine, Lampang of IS/TIA, MB, ICH, HF, and death was 1.43 (1.17–1.74), 2.11 (1.79–2.48), 0.70 (0.52–0.92), Hospital, Lampang, Thailand; 3Division of Cardiology, Department of Medicine, 3.03 (2.64–3.46), and 3.77 (3.33–4.24) per 100 person-years, respectively. -
Development of Palliative Care Model Using Thai Traditional Medicine for Treatment of End-Stage Liver Cancer Patients in Thai Traditional Medicine Hospitals
DEVELOPMENT OF PALLIATIVE CARE MODEL USING THAI TRADITIONAL MEDICINE FOR TREATMENT OF END-STAGE LIVER CANCER PATIENTS IN THAI TRADITIONAL MEDICINE HOSPITALS By MR. Preecha NOOTIM A Thesis Submitted in Partial Fulfillment of the Requirements for Doctor of Philosophy (SOCIAL AND ADMINISTRATIVE PHARMACY) Graduate School, Silpakorn University Academic Year 2019 Copyright of Graduate School, Silpakorn University - โดย นายปรีชา หนูทิม วทิ ยานิพนธ์น้ีเป็นส่วนหน่ึงของการศึกษาตามหลกั สูตรเภสัชศาสตรดุษฎีบณั ฑิต สาขาวิชาเภสัชศาสตร์สังคมและการบริหาร แบบ 1.1 เภสัชศาสตรดุษฎีบัณฑิต บัณฑิตวิทยาลัย มหาวิทยาลัยศิลปากร ปีการศึกษา 2562 ลิขสิทธ์ิของบณั ฑิตวทิ ยาลยั มหาวิทยาลัยศิลปากร DEVELOPMENT OF PALLIATIVE CARE MODEL USING THAI TRADITIONAL MEDICINE FOR TREATMENT OF END-STAGE LIVER CANCER PATIENTS IN THAI TRADITIONAL MEDICINE HOSPITALS By MR. Preecha NOOTIM A Thesis Submitted in Partial Fulfillment of the Requirements for Doctor of Philosophy (SOCIAL AND ADMINISTRATIVE PHARMACY) Graduate School, Silpakorn University Academic Year 2019 Copyright of Graduate School, Silpakorn University Title Development of Palliative Care Model Using Thai Traditional Medicine for Treatment of End-stage Liver Cancer Patients in Thai Traditional Medicine Hospitals By Preecha NOOTIM Field of Study (SOCIAL AND ADMINISTRATIVE PHARMACY) Advisor Assistant Professor NATTIYA KAPOL , Ph.D. Graduate School Silpakorn University in Partial Fulfillment of the Requirements for the Doctor of Philosophy Dean of graduate school (Associate Professor Jurairat Nunthanid, Ph.D.) Approved by Chair -
The Incidence, Characteristics and Outcomes of Pneumothorax in Thai Surgical Intensive Care Units (Thai-SICU Study)
The Incidence, Characteristics and Outcomes of Pneumothorax in Thai Surgical Intensive Care Units (Thai-SICU Study) Sujaree Poopipatpab MD*1, Konlawij Trongtrakul MD*2, Chompunoot Pathonsamit MD*1, Siriporn Siraklow MD*1, Ploynapas Limphunudom MD*1, Kaweesak Chittawatanarat MD*3, the THAI-SICU study group *1 Department of Anesthesiology, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand *2 Division of Critical Care, Department of Emergency Medicine, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand *3 Department of Surgery, Chiang Mai University, Chiang Mai, Thailand Objective: To identify incidence, characteristics, and outcomes of pneumothorax among patients who specifically stayed in surgical intensive care units (SICUs). Material and Method: This was a multicenter prospective cohort study conducted in 9 University-affiliated SICUs in Thailand. Incidence of pneumothorax and its outcomes were evaluated from April 2011 to January 2013. Results: 4,652 patients who were admitted to SICU were enrolled. The incidence of pneumothorax was 0.5% (25 cases) in our study. Significant characteristics were found in the pneumothorax group, including: lower BMI, underlying malignancy and COPD, higher APACHE-II and SOFA score within 24 hours of first ICU admission, pulmonary infiltration pattern of chest imaging and usage of mechanical ventilation. In terms of outcome, there were higher SICU mortality and 28-day hospital mortality in pneumothorax than non-pneumothorax patients at 28.0% vs. 9.6%, p = 0.002 and at 44.0% vs. 13.6%, p<0.001, respectively. Conclusion: Patients admitted to surgical intensive care units who developed pneumothorax had higher risk of intensive care unit mortality and 28-day hospital mortality than non-pneumothorax patients, as well as a longer intensive care unit and hospital length of stays. -
Cost-Utility Analysis of 5-Fluorouracil and Capecitabine for Adjuvant Treatment in Locally Advanced Rectal Cancer
434 Original Article Cost-utility analysis of 5-fluorouracil and capecitabine for adjuvant treatment in locally advanced rectal cancer Kanyarat Katanyoo1, Imjai Chitapanarux2, Tharatorn Tungkasamit3, Somvilai Chakrabandhu2, Marisa Chongthanakorn1, Rungarun Jiratrachu4, Apiradee Kridakara5, Kanokpis Townamchai5, Pooriwat Muangwong6, Chokaew Tovanabutra7, Kittisak Chomprasert7 1Radiation Oncology Unit, Department of Radiation, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand; 2Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; 3Division of Radiation Oncology, Udornthani Cancer Hospital, Udornthani, Thailand; 4Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Prince of Songkla University, Songkla, Thailand; 5Department of Radiology, Bhumibol Adulyadej Hospital, Thailand; 6Division of Radiation Oncology, Lampang Cancer Hospital, Lampang, Thailand; 7Division of Radiation Oncology, Chonburi Cancer Hospital, Chonburi, Thailand Contributions: (I) Conception and design: K Katanyoo, I Chitapanarux; (II) Administrative support: K Katanyoo; (III) Provision of study material or patients: All authors; (IV) Collection and assembly of data: K Katanyoo; (V) Data analysis and interpretation: K Katanyoo; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Kanyarat Katanyoo, MD. Radiation Oncology Unit, Department of Radiology, Faculty of Medicine Vajira Hospital, Navamindradhiraj -
KHON KAEN Udon Thani 145 X 210 Mm
KHON KAEN Udon Thani 145 x 210 mm. Phrathat Kham Kaen CONTENTS KHON KAEN 8 City Attractions 9 Out-Of-City Attractions 15 Special Events 32 Local Product and Souvenirs 32 Suggested Itinerary 33 Golf Courses 35 Restaurants and Acoomodation 36 Important Telephone Numbers 36 How To Get There 36 UDON THANI 38 City Attractions 39 Out-Of-City Attractions 43 Special Events 51 Local Products and Souvenirs 52 Golf Courses 52 Suggested Itinerary 52 Important Telephone Numbers 55 How To Get There 55 Khon Kaen Khon Kaen Udon Thani Wat Udom Khongkha Khiri Khet Khon kaen Khon Kaen was established as a city over two hundred years ago during the reign of King Rama I, but the natural and historical evidences found in the area indicated that its history dates back much further. The ancient Khmer ruins, traces of human settlement in the prehistoric period, and the fossils of dinosaurs have proven the remarkable history and culture of Khon Kaen since millions of years ago. The strategic location at the heart of the Northeastern region makes Khon Kaen a hub of education, technology, commercial, trans- portation, and handicrafts of the region. One of the most famous crafts that illustrated the time-honoured local wisdom of Thai people is Mudmee silk and the production centre of this exquisite textile is in Khon Kaen. Khon Kaen boasts a diversity of attractions that makes for a memorable holiday where visitors can enjoy exploring a combination of breath taking natural wonders, fascinating historical treasures and cultural heritage, unique way of life, and extraordinary local wisdom.